Background: Systemic hypertension is the most common noncommunicable disease in Nigeria with a plethora of associated clinical conditions and target organ damage. Adequate blood pressure (Bp) reduction with antihypertensive medication is expected to reduce mortality and morbidity. However, although Bp is easy to measure and hypertension responds well to therapy, a significant number of hypertensive patients on medication are not well controlled and hence remain at risk for the complications of hypertension, since a significant number of patients do not reach the goal Bp of ≤140/90 mmHg. Methods: Case notes of 826 hypertensive patients seen over the past 5 years, who have had a minimum period of treatment of 6 months at the Medical Outpatient Department of the University of Benin Teaching Hospital, were retrospectively evaluated. All had antihypertensive medication prescribed and subjectively reported compliance with medications. Adequate Bp control was defined as a systolic Bp of <140 mmHg and a diastolic Bp of <90 mmHg according to the JNC VII definition. Results: There were 826 patients: 353 males and 473 females. Age range was 18-96 years. Mean age was males -56.54 (±17.34) years and females -53.83 (±15.1) years. Bp levels of <140/90 mmHg were found in a total of 40.92% of treated patients. Males had a total of 126 controlled out of 353 (35.69%) and females had a total of 212 controlled out of 473 (44.82%). Conclusion: Despite pharmacologic treatment, less than half of our treated patients were able to achieve adequate Bp control. These poor Bp control rates tend to reflect global trends. There is a need to objectively assess factors involved in Bp control so as to achieve a better outcome.
Introduction
Hypertension has been estimated to affect approximately 1 billion people worldwide, and this figure is expected to increase to 1.5 billion by 2025. [1] [2] [3] It is the number one risk factor for cardiovascular disease in Sub-Saharan Africa and thus has emerged as a major public health concern. [4] This is especially true in the African region where the prevalence of hypertension has been found to be between 11% and 46% in adults aged 25 years and above. [5] [6] [7] Figures from Ghana show the prevalence of 19.3% in rural areas to 54.6% in urban areas in studies from 11 surveys conducted between 1973 and 2009. [8] In Nigeria, in a review of 43 studies, the prevalence of hypertension was found to range from 8% to 46.4%. [9] While the technical workforce and medications used to treat hypertension are available worldwide as well as in Nigeria, inadequate blood pressure (Bp) control has been widely documented in the developed and in the developing world, including Nigeria. [10, 11] It has been shown that in spite of the availability of a wide range of antihypertensives, hypertension and its complications are still important causes of adult morbidity and mortality in Sub-Saharan Africa and the rest of the world. [12, 13] Hypertension has been estimated to account for 13.5% of deaths worldwide, [14] and it is the most common treatable risk factor for cardiovascular disease. [15] It has also been found to be a major cause of cardiac failure, myocardial infarction, retinopathy, cerebrovascular accidents, and hypertensive nephrosclerosis leading to renal failure, among others. [16, 17] These studies have also shown that a reduction in Bp effectively prevents these cardiovascular events. Furthermore, systemic hypertension has been found to be a leading risk factor for cardiovascular disease among Negroid, and This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
For reprints contact: reprints@medknow.com excess morbidity and mortality have been observed among blacks relative to their Caucasian counterparts. [18, 19] Fortunately, studies have proved conclusively that Bp reductions to optimal levels are directly related to a more favorable disease outcome. Thus, the reduction of Bp to optimal levels with pharmacological agents has been found to be beneficial. [20] However, several studies have shown that only about 5%-55% of treated hypertensives are adequately controlled using the cutoff point of 140/90 mmHg as the goal Bp. [21] [22] [23] This study is notable in the sense that it suggests that factors other than that of affordability of antihypertensive medication may play a significant role in adequate Bp control.
Methods
The case files of 826 hypertensive patients attending clinic at the Medical Outpatient Department of the University of Benin Teaching Hospital were retrospectively evaluated. Bp readings, taken at routine clinic visits, were assessed. Mean Bp value of each patient over the last three clinic visits were calculated and taken for the value of this study. Hypertension was defined as a systolic Bp (SBp) >140 mmHg and a diastolic Bp (DBp) >90 mmHg according to JNC 7.
Control in treated patients was defined as the number of patients achieving the goal Bp of 140/90 mmHg divided by the total number of patients and expressed as a percentage.
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Results

Discussion
The current study found that only 40.92% of our patients achieved the goal Bp of 140/90 mmHg. These study results are important in several ways. The main objective of antihypertensive therapy is to lower the Bp to optimal levels using pharmacological agents, as this has been found to markedly reduce the complications of hypertension. If, however, the treated patients do not achieve their goal Bp, then they continue to be at risk for the complications of hypertension, especially cardiovascular disorders.
In addition, they are also at risk from the side effects of medications without the optimum benefits of those medications. Our result is close to that of Isezuo and Njoku in Uthman Dan Fodio University Teaching Hospital, which had a control rate of 42.7%, [24] a figure which is slightly higher than the results obtained in our environment, and much higher than that observed by Salako et al., who did their studies in a patient population where antihypertensive medication were given free and found a control rate of 36%. [8] Our results, however, are higher than that of Yusuf and Balogun who found 29% of their patients were adequately controlled. [25] 
Conclusion
The number of patients reaching goal Bp of 140/90 mmHg is still poor, and in keeping with studies, both in Nigeria and other places in the world.
There is a need to do a widespread audit of the effects of antihypertensive therapy to find out whether we are actually achieving the setout targets in Bp control in our treated hypertensive patients. Further studies are required to find out those factors associated with poor Bp control in treated hypertensive patients. This will enable important changes to be made to enable more treated patients benefit from the advantages of Bp lowering and hence reduce the risks from the complications of hypertension.
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